Our identity
Convalence Labs is a global scientific firm built by senior analysts with over two decades of experience in qualitative and quantitative molecular identification. We exist to audit the real composition, purity, and exact dosage of peptides, proteins, and advanced active ingredients — every sample tested against certified reference standards sourced from the world's most rigorous chemical suppliers.
Competitive advantages
Technological guarantee
European-standard instrumentation with continuous calibration and preventive maintenance, keeping our margin of error near zero.
Proprietary methodologies
Complex organic compounds demand tailored screening. Our accumulated expertise shapes processes built for unquestionable data.
Specialized consultation
Our service doesn't end at the report. We stay reachable by phone and digital channels to help interpret results.
Ironclad privacy
A strict chain-of-custody and data-handling protocol keeps your identity, samples, and history fully confidential.
Coverage and scope
A logistics network built for the secure transport of chemical compounds lets us process analytical requests from anywhere in the world. We specialize in the thorough characterization of complex chemical matrices — including controlled substances, pharmaceuticals, and sports-related additives — supporting both private individuals and product-development companies. Every analysis ends with an unalterable digital report, instantly verifiable by any third party through our public platform.
Meet the team
Dr. Elena Voss
Lead Analytical Chemist
PhD in Analytical Chemistry, University of Warsaw. GC-MS characterization of anabolic-androgenic compounds, 12+ years in pharmaceutical and forensic labs.
Marco Ferretti
Senior Research Specialist, Peptides
MSc in Biochemistry, University of Bologna. Purity and dosage verification of bioactive peptides, including GLP-1 analogues.
Sofia Kaminski
NMR Applications Specialist
MSc in Chemistry, postgraduate studies in Pharmaceutical Analysis, University of Wrocław. Structural confirmation via NMR.
Placeholder profiles — to be replaced with the real team before launch.